BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24827996)

  • 1. Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer.
    Yamaguchi T; Kawahara A; Hattori S; Taira T; Abe H; Sanada S; Akiba J; Nishio S; Ushijima K; Kamura T; Kage M
    Cytopathology; 2015 Jun; 26(3):157-66. PubMed ID: 24827996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
    Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
    Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-cytological study of uterine papillary serous carcinoma.
    Hagiwara T; Kaku T; Kobayashi H; Hirakawa T; Nakano H
    Cytopathology; 2005 Jun; 16(3):125-31. PubMed ID: 15924607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes.
    Norimatsu Y; Irino S; Maeda Y; Yanoh K; Kurokawa T; Hirai Y; Kobayashi TK; Fulciniti F
    Cytopathology; 2021 Jan; 32(1):65-74. PubMed ID: 32794283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of squamous cell change associated with endometrial carcinoma: A cytopathologic approach.
    Toomine Y; Watanabe S; Sugishima S; Ohishi Y; Tamiya S; Kobayashi H; Sonoda K; Oda Y; Kato K; Kaku T
    Diagn Cytopathol; 2016 Mar; 44(3):187-94. PubMed ID: 26715072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cytology in serous and endometrioid endometrial cancer.
    Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
    Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial metaplasia: correlation of histological and cytological specimens obtained from 103 cases undergoing hysterectomy for endometrial carcinoma.
    Toomine Y; Watanabe S; Ohishi Y; Tamiya S; Sugishima S; Kobayashi H; Oda Y; Kaku T
    Cytopathology; 2014 Apr; 25(2):78-85. PubMed ID: 23517058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
    Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
    Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological Study of Grade 3 Endometrioid Adenocarcinoma of Endometrial Origin: Cytoarchitecture and Features of Cell Clusters Assessed With Endometrial Brushing Cytology--Focusing on a comparison with endometrioid adenocarcinoma Grade 1, 2.
    Matsui N; Kajiwara H; Morishita A; Tsukada H; Nakazawa K; Miyazawa M; Mikami M; Nakamura N; Sato S
    Tokai J Exp Clin Med; 2015 Jun; 40(2):29-35. PubMed ID: 26150180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.
    Alkushi A; Abdul-Rahman ZH; Lim P; Schulzer M; Coldman A; Kalloger SE; Miller D; Gilks CB
    Am J Surg Pathol; 2005 Mar; 29(3):295-304. PubMed ID: 15725797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation profiles of endometrioid and serous endometrial cancers.
    Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic validity of neoplastic cells with notable nuclear atypia in endometrial cancer.
    Takeshima N; Hirai Y; Hasumi K
    Obstet Gynecol; 1998 Jul; 92(1):119-23. PubMed ID: 9649106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
    Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
    Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
    Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
    Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using classification and regression trees, liquid-based cytology and nuclear morphometry for the discrimination of endometrial lesions.
    Pouliakis A; Margari C; Margari N; Chrelias C; Zygouris D; Meristoudis C; Panayiotides I; Karakitsos P
    Diagn Cytopathol; 2014 Jul; 42(7):582-91. PubMed ID: 24273089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometrical Differences among Endometrial Endometrioid Carcinoma Grade 1, Grade 3, and Serous Carcinoma in Endometrial Liquid-Based Cytology Preparations.
    Odashima H; Yoshioka H; Minami K; Miyakawa K; Horie K; Norimatsu Y; Yanoh K; Watanabe J
    Acta Cytol; 2022; 66(6):524-531. PubMed ID: 36096095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.